What is ZBiotics?
ZBiotics operates at the intersection of synthetic biology and consumer wellness, specializing in the development of genetically engineered probiotics. The company's flagship product portfolio includes innovative solutions such as Pre-Alcohol, designed to mitigate the physiological impact of acetaldehyde, and Sugar-to-Fiber, a proprietary technology that converts dietary sugars into beneficial fiber within the gut. By focusing on tangible, everyday health outcomes, ZBiotics distinguishes itself from traditional supplement providers, positioning its products as functional tools for improved biological performance. The company's commitment to transparency and scientific rigor has allowed it to carve out a unique niche in the biotechnology landscape, effectively bridging the gap between complex laboratory research and accessible, high-impact consumer goods.
How much funding has ZBiotics raised?
ZBiotics has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2024): $12M with participation from Seamless Capital, Seaside Ventures, and SpringTide Ventures
Key Investors in ZBiotics
Seamless Capital
Seamless Capital is a firm operating within the commercial and residential construction sector, providing strategic financial support to emerging enterprises.
Seaside Ventures
Seaside Ventures specializes in identifying and scaling high-potential direct-to-consumer brands, offering both capital and operational insights to drive market success.
SpringTide Ventures
SpringTide Ventures is a specialized investment firm focused on early-stage healthcare and health-tech companies, dedicated to advancing innovation in care delivery and global wellness.
What's next for ZBiotics?
Looking ahead, the strategic deployment of the $12M will likely focus on scaling manufacturing capabilities and expanding the company's distribution channels. As ZBiotics moves into this next phase of growth, the focus will shift toward optimizing supply chain efficiencies and deepening its research and development pipeline to introduce new probiotic applications. The company is expected to leverage its recent capital to enhance its brand visibility and explore new market segments, potentially diversifying its product offerings to address a wider array of wellness challenges. With strong institutional backing, ZBiotics is poised to set new benchmarks for the commercialization of synthetic biology in the consumer market, driving long-term value for stakeholders and consumers alike.
See full ZBiotics company page
